Mineral Supplements Market Size, Share & Trends Analysis Report By Product (Calcium, Magnesium, Iron, Potassium, Zinc, Chromium, Selenium), By End-use, By Formulation, By Application, By Sales Channel, By Region, And Segment Forecasts, 2023 - 2030

Mineral Supplements Market Growth & Trends


The global mineral supplements market size is expected to reach USD 19.97 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 3.3% from 2023 to 2030. The major factor influencing the industry growth is the growing worldwide incidences of chronic diseases such as anemia, osteoporosis, cancer, and diabetes is boosting the growth as these supplements are useful for managing such conditions. The rising adoption of a sedentary lifestyle has led to the rising cases of lifestyle disorders

For instance, as per the report of the National Diabetes Statistics report released in 2022, 11.3% of the overall U.S. population were diagnosed with diabetes. Due to unhealthy dietary habits, the majority of the population is expected to deal with vital nutrient deficiencies, particularly iron and calcium, therefore driving the consumption and demand for nutritional supplementation. Furthermore, an increasing percentage of working- and middle-class people, along with growing disposable income, is projected to boost demand in the coming years. A large percentage of the population is willing to pay more for functional food, which includes nutrient supplementation.

Many key participants are focusing on introducing novel products consisting of new exotic ingredients. Moreover, the growing trend of vegan products is expected to produce new opportunities for the industry. Growing consumer preference for preventive healthcare is also one of the key factors augmenting the product demand. Increasing awareness about the benefits of nutrient supplementation among consumers is further expected to fuel the demand for mineral supplements.

COVID-19 had a favorable impact on market growth since some studies suggested that taking higher dosages of mineral supplements could assist COVID-19 patients lower viral load and reducing hospitalizations. As a result, the population's demand for nutritional supplementation is growing. However, the presence of counterfeit products in the market is expected to hamper the growth.

Mineral Supplements Market Report Highlights
  • The market growth can be attributed to the increasing prevalence of diseases such as osteoporosis, anemia, cancer, and diabetes
  • The calcium supplement segment accounted for the largest revenue share of over 27.2%in 2022 as a large percentage of women and the elderly population are suffering from osteoporosis due to calcium deficiency in the body
  • Asia Pacific dominated the market with a revenue share of over 52.5% in 2022 owing to the increasing disposable income, increasing prevalence of lifestyle disorders, growing elderly population, and growing adoption of a healthy lifestyle
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Information analysis
1.2.2. Market formulation & data visualization
1.2.3. Data validation & publishing
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Formulation & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Increasing geriatric population
3.3.2. Rising mineral deficiencies in working population
3.3.3. Increasing bone related sports injuries
3.4. Market Restraint Analysis
3.4.1. Low awareness levels in emerging economies
3.5. Business Environment Analysis
3.5.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.5.2. Porter’s Five Forces Analysis
3.6. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Mineral Supplements market: Product Movement Analysis
4.2. Calcium
4.2.1. Calcium Market, 2018 - 2030 (USD Million)
4.3. Magnesium
4.3.1. Magnesium Market, 2018 - 2030 (USD Million)
4.4. Iron
4.4.1. Iron Market, 2018 - 2030 (USD Million)
4.5. Potassium
4.5.1. Potassium Market, 2018 - 2030 (USD Million)
4.6. Zinc
4.6.1. Zinc Market, 2018 - 2030 (USD Million)
4.7. Chromium
4.7.1. Chromium Market, 2018 - 2030 (USD Million)
4.8. Selenium
4.8.1. Selenium Market, 2018 - 2030 (USD Million)
4.9. Other
4.9.1. Other Market, 2018 - 2030 (USD Million)
Chapter 5. Formulation Business Analysis
5.1. Mineral Supplements market: Formulation Movement Analysis
5.2. Capsule
5.2.1. Capsule Market, 2018 - 2030 (USD Million)
5.3. Tablet
5.3.1. Tablet Market, 2018 - 2030 (USD Million)
5.4. Powder
5.4.1. Powder Market, 2018 - 2030 (USD Million)
5.5. Liquid/Gel
5.5.1. Liquid/Gel Market, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. Application Business Analysis
6.1. Mineral Supplements market: Application Movement Analysis
6.2. General Health
6.2.1. General Health Market, 2018 - 2030 (USD Million)
6.3. Bone & Joint Health
6.3.1. Bone & Joint Health Market, 2018 - 2030 (USD Million)
6.4. Gastrointestinal Health
6.4.1. Gastrointestinal Health Market, 2018 - 2030 (USD Million)
6.5. Immunity
6.5.1. Immunity Market, 2018 - 2030 (USD Million)
6.6. Others
6.6.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. End-Use Business Analysis
7.1. Mineral Supplements market: End-Use Movement Analysis
7.2. Adults
7.2.1. Adults Market, 2018 - 2030 (USD Million)
7.3. Geriatric
7.3.1. Geriatric Market, 2018 - 2030 (USD Million)
7.4. Pregnant Women
7.4.1. Pregnant Women Market, 2018 - 2030 (USD Million)
7.5. Children
7.5.1. Children Market, 2018 - 2030 (USD Million)
7.6. Infants
7.6.1. Infants Market, 2018 - 2030 (USD Million)
Chapter 8. Sales Channel Business Analysis
8.1. Mineral Supplements market: Sales Channel Movement Analysis
8.2. Pharmacies & Drug Stores
8.2.1. Pharmacies & Drug Stores Market, 2018 - 2030 (USD Million)
8.3. Supermarkets & Hypermarkets
8.3.1. Supermarkets & Hypermarkets Market, 2018 - 2030 (USD Million)
8.4. Online Channels
8.4.1. Online Channels Market, 2018 - 2030 (USD Million)
Chapter 9. Regional Business Analysis
9.1. Mineral Supplements market Share By Region, 2022 & 2030
9.2. North America
9.2.1. SWOT Analysis
9.2.2. North America Mineral Supplements market, 2018 - 2030 (USD Million)
9.2.3. U.S.
9.2.3.1. Key Country Dynamics
9.2.3.2. Competitive Scenario
9.2.3.3. Regulatory Framework
9.2.3.4. Target Disease Prevalence
9.2.3.5. U.S. Mineral Supplements market, 2018 - 2030 (USD Million)
9.2.4. Canada
9.2.4.1. Key Country Dynamics
9.2.4.2. Competitive Scenario
9.2.4.3. Regulatory Framework
9.2.4.4. Target Disease Prevalence
9.2.4.5. Canada Mineral Supplements market, 2018 - 2030 (USD Million)
9.3. Europe
9.3.1. SWOT Analysis
9.3.2. Europe Mineral Supplements market, 2018 - 2030 (USD Million)
9.3.3. Germany
9.3.3.1. Key Country Dynamics
9.3.3.2. Competitive Scenario
9.3.3.3. Regulatory Framework
9.3.3.4. Target Disease Prevalence
9.3.3.5. Germany Mineral Supplements market, 2018 - 2030 (USD Million)
9.3.4. UK
9.3.4.1. Key Country Dynamics
9.3.4.2. Competitive Scenario
9.3.4.3. Regulatory Framework
9.3.4.4. Target Disease Prevalence
9.3.4.5. UK Mineral Supplements market, 2018 - 2030 (USD Million)
9.3.5. France
9.3.5.1. Key Country Dynamics
9.3.5.2. Competitive Scenario
9.3.5.3. Regulatory Framework
9.3.5.4. Target Disease Prevalence
9.3.5.5. France Mineral Supplements market, 2018 - 2030 (USD Million)
9.3.6. Italy
9.3.6.1. Key Country Dynamics
9.3.6.2. Competitive Scenario
9.3.6.3. Regulatory Framework
9.3.6.4. Target Disease Prevalence
9.3.6.5. Italy Mineral Supplements market, 2018 - 2030 (USD Million)
9.3.7. Spain
9.3.7.1. Key Country Dynamics
9.3.7.2. Competitive Scenario
9.3.7.3. Regulatory Framework
9.3.7.4. Target Disease Prevalence
9.3.7.5. Spain Mineral Supplements market, 2018 - 2030 (USD Million)
9.3.8. Denmark
9.3.8.1. Key Country Dynamics
9.3.8.2. Competitive Scenario
9.3.8.3. Regulatory Framework
9.3.8.4. Target Disease Prevalence
9.3.8.5. Denmark Mineral Supplements market, 2018 - 2030 (USD Million)
9.3.9. Sweden
9.3.9.1. Key Country Dynamics
9.3.9.2. Competitive Scenario
9.3.9.3. Regulatory Framework
9.3.9.4. Target Disease Prevalence
9.3.9.5. Sweden Mineral Supplements market, 2018 - 2030 (USD Million)
9.3.10. Norway
9.3.10.1. Key Country Dynamics
9.3.10.2. Competitive Scenario
9.3.10.3. Regulatory Framework
9.3.10.4. Target Disease Prevalence
9.3.10.5. Norway Mineral Supplements market, 2018 - 2030 (USD Million)
9.4. Asia Pacific
9.4.1. SWOT Analysis
9.4.2. Asia Pacific Mineral Supplements market, 2018 - 2030 (USD Million)
9.4.3. Japan
9.4.3.1. Key Country Dynamics
9.4.3.2. Competitive Scenario
9.4.3.3. Regulatory Framework
9.4.3.4. Target Disease Prevalence
9.4.3.5. Japan Mineral Supplements market, 2018 - 2030 (USD Million)
9.4.4. China
9.4.4.1. Key Country Dynamics
9.4.4.2. Competitive Scenario
9.4.4.3. Regulatory Framework
9.4.4.4. Target Disease Prevalence
9.4.4.5. China Mineral Supplements market, 2018 - 2030 (USD Million)
9.4.5. India
9.4.5.1. Key Country Dynamics
9.4.5.2. Competitive Scenario
9.4.5.3. Regulatory Framework
9.4.5.4. Target Disease Prevalence
9.4.5.5. India Mineral Supplements market, 2018 - 2030 (USD Million)
9.4.6. South Korea
9.4.6.1. Key Country Dynamics
9.4.6.2. Competitive Scenario
9.4.6.3. Regulatory Framework
9.4.6.4. Target Disease Prevalence
9.4.6.5. South Korea Mineral Supplements market, 2018 - 2030 (USD Million)
9.4.7. Australia
9.4.7.1. Key Country Dynamics
9.4.7.2. Competitive Scenario
9.4.7.3. Regulatory Framework
9.4.7.4. Target Disease Prevalence
9.4.7.5. Australia Mineral Supplements market, 2018 - 2030 (USD Million)
9.4.8. Thailand
9.4.8.1. Key Country Dynamics
9.4.8.2. Competitive Scenario
9.4.8.3. Regulatory Framework
9.4.8.4. Target Disease Prevalence
9.4.8.5. Thailand Mineral Supplements market, 2018 - 2030 (USD Million)
9.5. Latin America
9.5.1. SWOT Analysis
9.5.2. Latin America Mineral Supplements market, 2018 - 2030 (USD Million)
9.5.3. Brazil
9.5.3.1. Key Country Dynamics
9.5.3.2. Competitive Scenario
9.5.3.3. Regulatory Framework
9.5.3.4. Target Disease Prevalence
9.5.3.5. Brazil Mineral Supplements market, 2018 - 2030 (USD Million)
9.5.4. Mexico
9.5.4.1. Key Country Dynamics
9.5.4.2. Competitive Scenario
9.5.4.3. Regulatory Framework
9.5.4.4. Target Disease Prevalence
9.5.4.5. Mexico Mineral Supplements market, 2018 - 2030 (USD Million)
9.5.5. Argentina
9.5.5.1. Key Country Dynamics
9.5.5.2. Competitive Scenario
9.5.5.3. Regulatory Framework
9.5.5.4. Target Disease Prevalence
9.5.5.5. Argentina Mineral Supplements market, 2018 - 2030 (USD Million)
9.6. MEA
9.6.1. SWOT Analysis
9.6.2. MEA Mineral Supplements market, 2018 - 2030 (USD Million)
9.6.3. South Africa
9.6.3.1. Key Country Dynamics
9.6.3.2. Competitive Scenario
9.6.3.3. Regulatory Framework
9.6.3.4. Target Disease Prevalence
9.6.3.5. South Africa Mineral Supplements market, 2018 - 2030 (USD Million)
9.6.4. Saudi Arabia
9.6.4.1. Key Country Dynamics
9.6.4.2. Competitive Scenario
9.6.4.3. Regulatory Framework
9.6.4.4. Target Disease Prevalence
9.6.4.5. Saudi Arabia Mineral Supplements market, 2018 - 2030 (USD Million)
9.6.5. UAE
9.6.5.1. Key Country Dynamics
9.6.5.2. Competitive Scenario
9.6.5.3. Regulatory Framework
9.6.5.4. Target Disease Prevalence
9.6.5.5. UAE Mineral Supplements market, 2018 - 2030 (USD Million)
9.6.6. Kuwait
9.6.6.1. Key Country Dynamics
9.6.6.2. Competitive Scenario
9.6.6.3. Regulatory Framework
9.6.6.4. Target Disease Prevalence
9.6.6.5. Kuwait Mineral Supplements market, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Company Categorization
10.2. Strategy Mapping
10.3. Company Profiles/Listing
10.3.1. Glanbia, PLC.
10.3.1.1. Overview
10.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.3.1.3. Product Benchmarking
10.3.1.4. Strategic Initiatives
10.3.2. Abbott
10.3.2.1. Overview
10.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.3.2.3. Product Benchmarking
10.3.2.4. Strategic Initiatives
10.3.3. Nestle
10.3.3.1. Overview
10.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.3.3.3. Product Benchmarking
10.3.3.4. Strategic Initiatives
10.3.4. Biovea
10.3.4.1. Overview
10.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.3.4.3. Product Benchmarking
10.3.4.4. Strategic Initiatives
10.3.5. Herballife International of America, Inc.
10.3.5.1. Overview
10.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.3.5.3. Product Benchmarking
10.3.5.4. Strategic Initiatives
10.3.6. Sanofi
10.3.6.1. Overview
10.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.3.6.3. Product Benchmarking
10.3.6.4. Strategic Initiatives
10.3.7. Omega Protein Corporation
10.3.7.1. Overview
10.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.3.7.3. Product Benchmarking
10.3.7.4. Strategic Initiatives
10.3.8. Bio Botanica, Inc
10.3.8.1. Overview
10.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.3.8.3. Product Benchmarking
10.3.8.4. Strategic Initiatives
10.3.9. Pharmavite LLC
10.3.9.1. Overview
10.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.3.9.3. Product Benchmarking
10.3.9.4. Strategic Initiatives
10.3.10. DSM
10.3.10.1. Overview
10.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.3.10.3. Product Benchmarking
10.3.10.4. Strategic Initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings